| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | 2-Oxo-3-Hydroxy-Lysergate diethylamide/Creatinine | LP435646-7 |
| PROPERTY | MRto | LP6834-8 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Urine | LP7681-2 |
| SCALE_TYP | Qn | LP7753-9 |
| METHOD_TYP | Confirm | LP6197-0 |
| parent | 2-Oxo-3-Hydroxy-Lysergate diethylamide | Urine | Drug toxicology | LP389758-6 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Observation | |
| EXAMPLE_UNITS | ng/mg | |
| EXAMPLE_UCUM_UNITS | ng/mg | |
| UNITSREQUIRED | N |
| LONG_COMMON_NAME | en-US | 2-Oxo-3-Hydroxy-Lysergate diethylamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| LONG_COMMON_NAME | en-US | 2-Oxo-3-Hydroxy-Lysergate diethylamide/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| SHORTNAME | en-US | 2-oxo-3-OH-LDS/Creat Ur Cfm |
| ConsumerName | en-US | 2-Oxo-3-Hydroxy-Lysergate diethylamide/Creatinine, Urine |
| LONG_COMMON_NAME | nl-NL | 2-oxo-3-hydroxy-lysergatedi-ethylamide/creatinine [massaverhouding] in urine d.m.v. bevestiging |
LOINC Version: 2.77
FHIR